ICON 9

Trial Description: 
An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
Lead Cooperative Group: 
Participating Groups: 
Disease Site: 
Recurrent Maintenance Ovarian
Trial Status: 
Recruiting
Contact person: